NNN

HARM REDUCTION GROUP AB

No trades
See on Supercharts
Market capitalization
‪38.70 M‬SEK
−0.1385SEK
‪−24.71 M‬SEK
‪168.57 M‬SEK
Beta (1Y)
−0.88

About HARM REDUCTION GROUP AB

CEO
Marius Arnesen
Headquarters
Gothenburg
Founded
2012
ISIN
SE0006261038
FIGI
BBG0073XKCQ1
Harm Reduction Group AB engages in the development and trade of nicotine alternative products. It carries the MAXSNUS and NorDamp brands. The firm offers e-cigarettes and snus. The company was founded on April 18, 2012 and is headquartered in Gothenburg, Sweden.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of NOHARM is 0.1200 SEK — it has decreased by 8.75% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange HARM REDUCTION GROUP AB stocks are traded under the ticker NOHARM.
NOHARM stock is 31.50% volatile and has beta coefficient of −0.88. Check out the list of the most volatile stocks — is HARM REDUCTION GROUP AB there?
HARM REDUCTION GROUP AB revenue for the last quarter amounts to ‪45.60 M‬ SEK despite the estimated figure of ‪50.30 M‬ SEK. In the next quarter revenue is expected to reach ‪53.00 M‬ SEK.
Yes, you can track HARM REDUCTION GROUP AB financials in yearly and quarterly reports right on TradingView.
NOHARM stock has fallen by 0.83% compared to the previous week, the month change is a 31.03% fall, over the last year HARM REDUCTION GROUP AB has showed a 58.62% decrease.
NOHARM net income for the last quarter is ‪−9.25 M‬ SEK, while the quarter before that showed ‪−4.14 M‬ SEK of net income which accounts for −123.46% change. Track more HARM REDUCTION GROUP AB financial stats to get the full picture.
Today HARM REDUCTION GROUP AB has the market capitalization of ‪35.32 M‬, it has decreased by 12.27% over the last week.
No, NOHARM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NOHARM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HARM REDUCTION GROUP AB stock right from TradingView charts — choose your broker and connect to your account.
NOHARM reached its all-time high on Jul 20, 2023 with the price of 0.3650 SEK, and its all-time low was 0.1130 SEK and was reached on Apr 24, 2024.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HARM REDUCTION GROUP AB technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HARM REDUCTION GROUP AB stock shows the strong sell signal. See more of HARM REDUCTION GROUP AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HARM REDUCTION GROUP AB EBITDA is ‪−8.22 M‬ SEK, and current EBITDA margin is −4.87%. See more stats in HARM REDUCTION GROUP AB financial statements.